- Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer.
- Huang TT, Burkett SS, Tandon M, Yamamoto TM, Gupta N, Bitler BG, Lee JM, Nair JR.
- Oncogene. 2022 Oct 12. doi: 10.1038/s41388-022-02491-8. Epub ahead of print.
- PMID: 36224341
- PubMed abstract
- Source abstract
- Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis.
- Ray T.
- Precision Oncology News. 2022 Oct 12.
- Case report
- Free Full Text
Special article:
Is there a duty to reinterpret genetic data? The ethical dimensions.
- PMID: 31616070
- PubMed abstract
- Free Full Text
- PARP-inhibition reprograms macrophages toward an anti-tumor phenotype.
- Wang L, Wang D, Sonzogni O, Ke S, Wang Q, Thavamani A, Batalini F, Stopka SA, Regan MS, Vandal S, Tian S, Pinto J, Cyr AM, Bret-Mounet VC, Baquer G, Eikesdal HP, Yuan M, Asara JM, Heng YJ, Bai P, Agar NYR, Wulf GM.
- Cell Rep. 2022 Oct 11;41(2):111462. doi: 10.1016/j.celrep.2022.111462.
- PMID: 36223740
- PubMed abstract